Morphine Sulfate & Fentanyl (NDPS High-Alert Opioid Analgesics)
Pure Mu-Opioid Receptor Agonists ā Narcotic Analgesics (NDPS Act 1985 / Essential Narcotic Drugs [END] | HIGH-ALERT) • Schedule H1 / Schedule X & NDPS Act 1985 Psychotropic/Narcotic Prescription Drug (Strict Statutory Register)
Level 1 ā Quick Professional Summary (At a Glance)
Morphine Sulfate & Fentanyl (NDPS High-Alert Opioid Analgesics)
Monograph Code: [7.20] | Stable ID: TIP-MED-000122
Representative Indian Market Examples (Edition 2.7 Ch 07 [7.20], p. 88): Morphine: Morphitroy (Troikaa), Morcontin Continus (Modi Mundipharma), Vermor. Fentanyl: Durogesic Transdermal Patch (J&J), Fenstud, Trofentyl (IV) ā Strengths & Dosage Forms: Morphine IR Tablets: 10 mg, 20 mg; SR/CR Tablets: 10 mg, 30 mg, 60 mg; Oral Solution: 10 mg/5mL; IV/SC Injection: 10 mg/mL. Fentanyl Transdermal Patch (72-Hour): 12 mcg/h, 25 mcg/h, 50 mcg/h; IV: 50 mcg/mL
Pure Mu-Opioid Receptor Agonists ā Narcotic Analgesics (NDPS Act 1985 / Essential Narcotic Drugs [END] | HIGH-ALERT)
Pain, Inflammation, Rheumatology & Gout Medicines (Ch 07)
Morphine IR Tablets: 10 mg, 20 mg; SR/CR Tablets: 10 mg, 30 mg, 60 mg; Oral Solution: 10 mg/5mL; IV/SC Injection: 10 mg/mL. Fentanyl Transdermal Patch (72-Hour): 12 mcg/h, 25 mcg/h, 50 mcg/h; IV: 50 mcg/mL; Morphine IR Tablets: 10 mg, 20 mg; SR/CR Tablets: 10 mg, 30 mg, 60 mg; Oral Solution: 10 mg/5mL; IV/SC Injection: 10 mg/mL. Fentanyl Transdermal Patch (72-Hour): 12 mcg/h, 25 mcg/h, 50 mcg/h; IV: 50 mcg/mL
Route: Oral / Parenteral / Topical as specified by formulation
9ā10. Mechanism of Action & Pharmacodynamics
Pure Mu-Opioid Receptor Agonists ā Narcotic Analgesics (NDPS Act 1985 / Essential Narcotic Drugs [END] | HIGH-ALERT) acting on target receptor/enzyme pathways in Pain, Inflammation, Rheumatology & Gout Medicines (Ch 07): clinical efficacy is mediated via Pure Mu-Opioid Receptor Agonists ā Narcotic Analgesics (NDPS Act 1985 / Essential Narcotic Drugs [END] | HIGH-ALERT) for Moderate-to-severe cancer pain (WHO Step 3 Palliative Care Ladder), acute myocardial infarction / cardiogenic pulmonary oedema pain, severe postoperative/trauma pain (Fentanyl is preferred over Morphine in severe CKD Stage 4ā5!).
12. Therapeutic Indications
- Moderate-to-severe cancer pain (WHO Step 3 Palliative Care Ladder), acute myocardial infarction / cardiogenic pulmonary oedema pain, severe postoperative/trauma pain (Fentanyl is preferred over Morphine in severe CKD Stage 4ā5!)
13 & 16. Contraindications, Precautions & Warnings
- NDPS ACT 1985 / ESSENTIAL NARCOTIC DRUGS (END) STATUTORY GOVERNANCE: Requires NDPS license/register, double-lock custody, and shift-to-shift balance! Contraindicated in respiratory depression, acute bronchial asthma, paralytic ileus, raised intracranial pressure/head injury. Fentanyl Patch is CONTRAINDICATED in opioid-naive patients or acute postoperative pain!
Renal: AVOID Morphine if eGFR <30 mL/min (active M6G/M3G metabolites cause prolonged coma & myoclonus ā use Fentanyl or Buprenorphine in severe CKD/dialysis!). Hepatic: Reduce dose and extend interval by 50% in cirrhosis
14. Dosage & Administration Context (Educational Reference Summary)
Administration & Timing: Swallow Morphine SR/CR tablets whole; ALWAYS co-prescribe a stimulant + osmotic laxative (Bisacodyl/Senna + Lactulose/PEG) from Day 1 (tolerance NEVER develops to opioid constipation!) | Morphine IR: Every 4 hours around the clock. Morphine SR: Every 12 hours. Fentanyl Patch: Every 72 hours
Level 2 ā Detailed Pharmacology, PK, Interactions & Special Populations
11 & 19. Pharmacokinetics (ADME), Renal & Hepatic Considerations
Pharmacokinetic Profile: Absorption, distribution, metabolism, and excretion follow class pharmacokinetic profile; verify patient renal/hepatic function.
Renal Considerations: Renal: AVOID Morphine if eGFR <30 mL/min (active M6G/M3G metabolites cause prolonged coma & myoclonus ā use Fentanyl or Buprenorphine in severe CKD/dialysis!). Hepatic: Reduce dose and extend interval by 50% in cirrhosis
Hepatic Considerations: Renal: AVOID Morphine if eGFR <30 mL/min (active M6G/M3G metabolites cause prolonged coma & myoclonus ā use Fentanyl or Buprenorphine in severe CKD/dialysis!). Hepatic: Reduce dose and extend interval by 50% in cirrhosis
15 & 17. Adverse Effects & Clinically Significant Drug Interactions
- Constipation (near 100% without prophylactic laxatives!), nausea/vomiting (during first 5ā7 days), drowsiness, miosis, pruritus, urinary retention
- Life-threatening respiratory depression (RR <8ā10/min, pinpoint pupils, coma -> reverse STAT with Naloxone 0.04ā0.4 mg IV titrated!), neuroexcitatory myoclonus/delirium in CKD (from M6G/M3G accumulation!), fatal Fentanyl overdose if patch is cut or exposed to heat/fever/hot-water bottle!
- Benzodiazepines, Zolpidem, Gabapentinoids, Alcohol, and Antihistamines cause synergistic fatal respiratory depression; CYP3A4 inhibitors (Clarithromycin, Itraconazole, Fluconazole, Diltiazem) markedly increase Fentanyl levels!
18, 20, 21 & 22. Special Populations, Monitoring, Counselling & Storage
Pregnancy, Lactation, Paediatric & Geriatric Use: Evaluate maternal-foetal benefit-risk ratio and age-appropriate organ function before prescribing.
Clinical & Laboratory Monitoring: Monitor clinical response, baseline renal/hepatic parameters, and relevant serum biomarkers.
Patient Counselling Points:- Patient Counselling Checklist: CRITICAL FENTANYL PATCH RULES: (1) Remove old patch before applying new patch every 72 hours; (2) NEVER cut a patch; (3) NEVER apply a heating pad/hot-water bottle over a patch or sit in hot water (heat increases Fentanyl absorption 3-fold and causes fatal overdose!); take your prescribed laxative daily with Morphine
- Meal & Clock Timing Instruction: Swallow Morphine SR/CR tablets whole; ALWAYS co-prescribe a stimulant + osmotic laxative (Bisacodyl/Senna + Lactulose/PEG) from Day 1 (tolerance NEVER develops to opioid constipation!) (Morphine IR: Every 4 hours around the clock. Morphine SR: Every 12 hours. Fentanyl Patch: Every 72 hours)
- Missed Dose Protocol: Take scheduled cancer-pain doses by the clock (do not wait for severe pain to return)
- Geriatric Dispensing Pearl: Start Morphine at 2.5ā5 mg IR q4ā6h in frail elderly; avoid Morphine if CrCl <30 mL/min
Storage & Dispensing Governance: Store below 25Ā°Cā30Ā°C in original moisture- and light-resistant packaging out of reach of children. Available forms: Morphine IR Tablets: 10 mg, 20 mg; SR/CR Tablets: 10 mg, 30 mg, 60 mg; Oral Solution: 10 mg/5mL; IV/SC Injection: 10 mg/mL. Fentanyl Transdermal Patch (72-Hour): 12 mcg/h, 25 mcg/h, 50 mcg/h; IV: 50 mcg/mL
Visual Pharmacology Mechanism Diagram (PLATE-8.1)
23. Traceable Source References & Jurisdiction
Primary Reference Record: Indian Pharmacist Desk Reference ā Professional Edition 2.7 (2026ā27) ā¢ Ch 07 [7.20] (p. 88)
Authoritative Verification Portals: Indian Pharmacopoeia Commission (IPC) • CDSCO (India Jurisdiction) • NCBI Bookshelf • DailyMed (US FDA Label Reference)
Last Checked Date: 2026-11-08 • Related Study Guide: Clinical Pharmacokinetics: ADME, Vd, Clearance & Half-Life →